The NIAID ClinRegs team thanks the following individuals and organizations for providing country-specific regulatory information and/or confirmations of accuracy for the ClinRegs country profiles.

Australia

• Jeremy Kenner, Ethics and Integrity Section, National Health and Medical Research Council (NHMRC)
• Therapeutic Goods Administration, Department of Health, Government of Australia
• Catherine Carey, Therapeutic and Vaccine Research Program, The Kirby Institute, UNSW Sydney
• Jonathon Doust, Linear Clinical Research

Brazil

• Sérgio Surugi de Siqueira, Pontifical Catholic University of Parana- Graduate Program of Bioethics
• Beatriz Grinsztejn, Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ
• Tania Kristic, Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ
• Valdilea Veloso, Instituto Nacional de Infectologia Evandro Chagas (INI) - FIOCRUZ

Canada

• Bureau of Policy, Science and International Programs, Health Canada
• Office of Clinical Trials, Health Canada

China

• Li Zhang, NIAID
• Ping Chen, NIAID
• Chrissie Cai, NIAID
• Lisa Goldfeder, NIAID

DRC

• Ydrissa Sow, NIAID
• Kelly Cahill, NIAID
• Christelle Perdrieu, Drugs for Neglected Diseases initiative
• Stuart Rennie, University of North Carolina-Chapel Hill, Department of Social Medicine
• Olivier Tshiani Mbaya, Leidos Biomedical Research, Inc.
• Nsengi Ntamabyalro, University of Kinshasa, Faculty of Medicine

Guinea

• Oumou Younoussa Bah-Sow, Comité National d'Ethique pour la Recherche en Santé
• Jamila Aboulhab, NIAID
• Alexandre Delamou, Centre National de Formation et de Recherche en Santé Rurale de Maferinyah
• Latifa El Hadri, United States Pharmacopeia-Global Public Health-Promoting the Quality of Medicine

India

• Gaurav Mathur, IQVIA
• Sarah McMullen, U.S. Food and Drug Administration (USFDA), India Office
• Kristan Callahan, USFDA, India Office
• Sudheendra Kulkarni, USFDA, India Office
• N.Kumarasamy, Voluntary Health Services (VHS) Infectious Diseases Medical Centre (IDMC) and Chennai Antiviral Research and Treatment Clinical Research Site (CART CRS)
• Barbara Bierer, Brigham and Women's Hospital and Harvard Medical School
• Nandita Chopra, National Institutes of Health (NIH)

Kenya

• Lydia Tuitai, Pharmacy and Poisons Board
• Edward Abwao, Pharmacy and Poisons Board
• Hettie Bouwer, Covance
• Eileen Pouliot, Division of AIDS, NIAID, NIH
• Elizabeth Ayuo, Kenya Medical Research Institute (KEMRI)
• Peter Odhiambo, FHI 360

Liberia

• Juwe Kercula, Liberia Medicines and Health Products Regulatory Authority (LMHRA)
• Gloria Mason, National Research Ethics Board (NREB)
• David Sumo, Liberia Medicines and Health Products Regulatory Authority (LMHRA)
• Jemee Tegli, University of Liberia-Pacific Institute for Research & Evaluation Africa Center
• Latifa El Hadri, United States Pharmacopeia-Global Public Health-Promoting the Quality of Medicines

Malawi

• Edwin Chipala, Pharmacy, Medicines and Poisons Board
• Terrie Taylor, Michigan State University and Blantyre Malaria Project, University of Malawi College of Medicine
• Damson Kathyola, Innova Training and Development Center
• Mina Hosseinipour, University of North Carolina School of Medicine and UNC Project Malawi
• Towera Banda, UNC Project Malawi
• Newton Kumwenda, Blantyre Health Research and Training Trust
• Billy Nyambalo, National Health Sciences Research Committee, Ministry of Health
• Tapiwa Munthali, UNC Project Lilongwe, Malawi

Mali

• Diakite Mahamadou, University Clinical Research Center (UCRC) University of Sciences, Techniques and Technology of Bamako
• Seydou Doumbia, University Clinical Research Center (UCRC) University of Sciences, Techniques and Technology of Bamako
• Fatoumata Guindo, University Clinical Research Center (UCRC) University of Sciences, Techniques and Technology of Bamako
• Cheick Oumar, University Clinical Research Center (UCRC), University of Sciences, Techniques and Technology of Bamako
• Lindsey Beaman, Leidos Biomedical Research, Inc.
• Elfrida Cline-Cole, Leidos Biomedical Research, Inc.
• Delphine Yamadjako, Leidos Biomedical Research, Inc.
• Shelly Simpson, Leidos Biomedical Research, Inc.

Mexico

• Juan Francisco Galan Herrera, La Red Mexicana de Investigación Clínica en Enfermedades Infecciosas Emergentes (LaRed)
• Michelle McConnell, U.S. Department of State
• Areli Cerón Sánchez, National Bioethics Commission of Mexico (CONBIOÉTICA)
• Mario Alanis Garza, Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS)
• Rosa Guadalupe Legaspi Jaime, Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS)

Peru

• Mey León, Asociación Civil Impacta Salud y Educación
• Sarah Carracedo Uribe, National Institute of Health of Peru
• Jorge Sanchez, Impacta Perú and Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales
• Carla Saenz, Pan American Health Organization (PAHO)
• Roxana Lascano, Research Administration Program, US Naval Medical Research Unit No. 6 and IRB member at Pontificia Universidad Católica del Perú and Instituto de Investigación Nutricional

Sierra Leone

• Shona Lee, London School of Hygiene & Tropical Medicine (LSHTM)
• Shelley Lees, London School of Hygiene & Tropical Medicine (LSHTM)
• Onome Abiri, Pharmacy Board of Sierra Leone
• Latifa El Hadri, United States Pharmacopeia-Global Public Health-Promoting the Quality of Medicines
• Wiltshire Johnson, Pharmacy Board of Sierra Leone

South Africa

• Clinical HIV Research Unit, WITS Health Consortium, University of the Witwatersrand
• Hanlie Bester, IAVI
• Duduzile Ndwandwe, Cochrane South Africa, South African Medical Research Council
• Elizabeth Pienaar, Cochrane South Africa, South African Medical Research Council
• Elizabeth Allen, Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town
• HIV Prevention Clinical Trials Unit, South African Medical Research Council
• Inge Vermeulen, University of Cape Town, Clinical Research Centre
• Lesley Henley, Division of Paediatrics, Faculty of Health Sciences, University of Cape Town
• Sarita Naidoo, South African Medical Research Council
• Tamara Kredo, Cochrane South Africa, South African Medical Research Council

Tanzania

• Kissa Mwamwitwa, Tanzania Medicines and Medical Devices Authority (TMDA)
• Kamaka Kasssimu, Ifakara Health Institute
• Alambo Mssusa, Tanzania Food and Drugs Authority
• Kilimanjaro Christian Research Institute (KCRI)
• Tooba Murshedkar, Sanaria, Inc.

Thailand

• Orawan Kijkuarn, FHI 360
• Suwan Sriviriakul, FHI 360
• Janet Robinson, FHI 360

Uganda

• Allan Tindikahwa, Makerere University Walter Reed Project
• Clemensia Nakabiito, Makerere U. Johns Hopkins U. Research Collaboration (MU-JHU Care LTD)
• Maria Musisi, Makerere U. Johns Hopkins U. Research Collaboration (MU-JHU Care LTD)
• Mary Glenn Fowler, Johns Hopkins U. School of Medicine

United Kingdom

• Birgit Whitman, University of Birmingham
• Clive Collett, Health Research Authority
• Fleur Hudson, University College London

Vietnam

• Dao Duc Giang, VietStar Biomedical Research
• Janet Robinson, FHI 360
• Laura Merson, Oxford University Clinical Research Unit Viet Nam
• Loc Truong Tho, FHI 360
• Nguyen Thi Phuong Dung, Oxford University Clinical Research Unit Viet Nam
• Vu Thi Lan, Oxford University Clinical Research Unit Viet Nam
• Tran Thi Minh Phuong, Oxford University Clinical Research Unit Viet Nam

Page Last Updated: April 5, 2021